I Peace, Inc.
PALO ALTO, CA · Founded 2015 · CIK 0001663601 · Biotech · Private
GMP-grade iPS cells, culture media, and custom cell manufacturing services
ipeace.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $47M
- 5 Form D · Feb 2025
- 20 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 29
- 12 granted · 17 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $5,140,000 | |
| Private capital raised | Form D · SEC | $6,000,000 | |
| Private capital raised | Form D · SEC | $17,760,889 | |
| Private capital raised | Form D · SEC | $8,499,990 | |
| Private capital raised | Form D · SEC | $9,699,983 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2232 | MITO-BIOTHERAPEUTICS, INC. | — | — |
| 2233 | CREEGH PHARMACEUTICALS INC | — | $500K |
| 2234 | Advac Therapeutic LLC | — | — |
| 2235 | I Peace, Inc. | — | $47M |
| 2236 | L.E.A.F. Pharmaceuticals LLC | — | $40M |
| 2237 | LOXIGEN, INC. | — | — |
| 2238 | KAPHA BIO, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Hideya HayashiDirector
- James PrentonExecutive Officer
- Tsunesaburo SugayaDirector · Executive Officer
- Koji TanabeDirector · Executive Officer
Patents
- Cell Production Device And System Thereforapplication
- Microscope Observation Systemapplication
- Microscope Observation Systemgranted
- Pharmaceutical Composition And Cosmetic Compositionapplication
- Cell Production Systemapplication
- Cell Production Systemapplication
- Pharmaceutical Composition And Cosmetic Compositiongranted
- Cell Production Systemgranted
- Unknownapplication
- Pharmaceutical Composition And Cosmetic Compositionapplication
- Method For Screening Substance, System For Screening Substance, Method For Producing A Clump From Stem Cells, And Method For Producing Differentiated Cellsapplication
- Pharmaceutical Composition And Cosmetic Compositiongranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.